Home » Newsletters » BioWorld

BioWorld

June 4, 1993

View Archived Issues

FDA SETS UP NEW SYSTEM TO REPORT ADVERSE REACTIONS

APPOINTMENTS AND ADVANCEMENTS

PACT WITH MMD WORTH $17.5M TO SEPRACOR

UNIVAX FILES PLA

PROCORDIA TO FOCUS ON BIOTECH

THREE-WAY PCR DISPUTE RESOLVED

GERON RAISES $10.7M IN VENTURE FINANCING

BAXTER DISTRIBUTES STEM-CELL SELECTION SYSTEM

RHONE BUYS 37% OF AIS FOR $113M

CENTORX ENTERS PHASE III FOR ANGINA

$20 MILLION ALPHA-BETA PRIVATE PLACEMENT

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...